메뉴 건너뛰기




Volumn 1, Issue 1, 2010, Pages 101-107

Vitamin D in combination cancer treatment

Author keywords

Calcitriol; Cancer; Chemotherapy; Vitamin D

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMETABOLITE; BRYOSTATIN 1; CALCITRIOL; CALCITRIOL DERIVATIVE; CAMPTOTHECIN; CARBOPLATIN; CARNOSIC ACID; CB 966; CISPLATIN; CYTARABINE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; FLUDARABINE; FLUOROURACIL; GEMCITABINE; GENISTEIN; HYDROXYUREA; IBUPROFEN; ILX 23 7553; INDOMETACIN; KETOCONAZOLE; LEXACALCITOL; MENADIONE; PACLITAXEL; PROSTAGLANDIN SYNTHASE INHIBITOR; SEOCALCITOL; TAMOXIFEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 79959770233     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.1.101     Document Type: Review
Times cited : (85)

References (74)
  • 2
    • 0038636398 scopus 로고    scopus 로고
    • Vitamin D: more than a "bone-a-fide" hormone
    • Sutton AL, MacDonald PN. Vitamin D: more than a "bone-a-fide" hormone. Mol Endocrinol 2003; 17: 777-91.
    • (2003) Mol Endocrinol , vol.17 , pp. 777-791
    • Sutton, A.L.1    MacDonald, P.N.2
  • 3
    • 0037224484 scopus 로고    scopus 로고
    • Nongenomic actions of steroid hormones
    • Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 2003; 4: 46-56.
    • (2003) Nat Rev Mol Cell Biol , vol.4 , pp. 46-56
    • Losel, R.1    Wehling, M.2
  • 4
    • 0345874610 scopus 로고    scopus 로고
    • Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model
    • Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004; 3: 27-41.
    • (2004) Nat Rev Drug Discov , vol.3 , pp. 27-41
    • Norman, A.W.1    Mizwicki, M.T.2    Norman, D.P.3
  • 6
    • 33645740073 scopus 로고    scopus 로고
    • Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
    • Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451-9.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 451-459
    • Giovannucci, E.1    Liu, Y.2    Rimm, E.B.3
  • 8
    • 58949095024 scopus 로고    scopus 로고
    • Vitamin D and cancer incidence in the Harvard cohorts
    • Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009; 19: 84-8.
    • (2009) Ann Epidemiol , vol.19 , pp. 84-88
    • Giovannucci, E.1
  • 9
    • 46449125088 scopus 로고    scopus 로고
    • Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer
    • Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008; 26: 2984-91.
    • (2008) J Clin Oncol , vol.26 , pp. 2984-2991
    • Ng, K.1    Meyerhardt, J.A.2    Wu, K.3
  • 10
    • 55849118096 scopus 로고    scopus 로고
    • Vitamin D status and the risk of lung cancer: a cohort study in Finland
    • Kilkkinen A, Knekt P, Heliovaara M, et al. Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomarkers Prev 2008; 17: 3274-8.
    • (2008) Cancer Epidemiol Biomarkers Prev , vol.17 , pp. 3274-3278
    • Kilkkinen, A.1    Knekt, P.2    Heliovaara, M.3
  • 11
    • 0028879760 scopus 로고
    • Cisplatin and DNA repair in cancer chemotherapy
    • Zamble DB, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 1995; 20: 435-9.
    • (1995) Trends Biochem Sci , vol.20 , pp. 435-439
    • Zamble, D.B.1    Lippard, S.J.2
  • 13
    • 0025851237 scopus 로고
    • Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells
    • Cho YL, Christensen C, Saunders DE, et al. Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells. Cancer Res 1991; 51: 2848-53.
    • (1991) Cancer Res , vol.51 , pp. 2848-2853
    • Cho, Y.L.1    Christensen, C.2    Saunders, D.E.3
  • 14
    • 0032587095 scopus 로고    scopus 로고
    • 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines
    • Moffatt KA, Johannes WU, Miller GJ. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res 1999; 5: 695-703.
    • (1999) Clin Cancer Res , vol.5 , pp. 695-703
    • Moffatt, K.A.1    Johannes, W.U.2    Miller, G.J.3
  • 15
    • 68049092791 scopus 로고    scopus 로고
    • Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model
    • Kulkarni AD, van Ginkel PR, Darjatmoko SR, Lindstrom MJ, Albert DM. Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model. Br J Ophthalmol 2009; 93: 1105-8.
    • (2009) Br J Ophthalmol , vol.93 , pp. 1105-1108
    • Kulkarni, A.D.1    van Ginkel, P.R.2    Darjatmoko, S.R.3    Lindstrom, M.J.4    Albert, D.M.5
  • 16
    • 49749146435 scopus 로고    scopus 로고
    • In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
    • Rassnick KM, Muindi JR, Johnson CS, et al. In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer Chemother Pharmacol 2008; 62: 881-91.
    • (2008) Cancer Chemother Pharmacol , vol.62 , pp. 881-891
    • Rassnick, K.M.1    Muindi, J.R.2    Johnson, C.S.3
  • 17
    • 0030880944 scopus 로고    scopus 로고
    • Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system
    • Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 1997; 57: 3759-64.
    • (1997) Cancer Res , vol.57 , pp. 3759-3764
    • Light, B.W.1    Yu, W.D.2    McElwain, M.C.3    Russell, D.M.4    Trump, D.L.5    Johnson, C.S.6
  • 18
    • 0036689119 scopus 로고    scopus 로고
    • Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression
    • Hershberger PA, McGuire TF, Yu WD, et al. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 2002; 1: 821-9.
    • (2002) Mol Cancer Ther , vol.1 , pp. 821-829
    • Hershberger, P.A.1    McGuire, T.F.2    Yu, W.D.3
  • 19
    • 54049152433 scopus 로고    scopus 로고
    • 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model
    • Ma Y, Yu WD, Hershberger PA, et al. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther 2008; 7: 3047-55.
    • (2008) Mol Cancer Ther , vol.7 , pp. 3047-3055
    • Ma, Y.1    Yu, W.D.2    Hershberger, P.A.3
  • 20
    • 0033557922 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage
    • Ravid A, Rocker D, Machlenkin A, et al. 1, 25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 1999; 59: 862-7.
    • (1999) Cancer Res , vol.59 , pp. 862-867
    • Ravid, A.1    Rocker, D.2    Machlenkin, A.3
  • 21
    • 0027988168 scopus 로고
    • Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen
    • Vink-van Wijngaarden T, Pols HA, Buurman CJ, et al. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen. Cancer Res 1994; 54: 5711-7.
    • (1994) Cancer Res , vol.54 , pp. 5711-5717
    • Vink-van Wijngaarden, T.1    Pols, H.A.2    Buurman, C.J.3
  • 22
    • 0027276092 scopus 로고
    • Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen
    • Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E, Ikeda K. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res 1993; 53: 2534-7.
    • (1993) Cancer Res , vol.53 , pp. 2534-2537
    • Abe-Hashimoto, J.1    Kikuchi, T.2    Matsumoto, T.3    Nishii, Y.4    Ogata, E.5    Ikeda, K.6
  • 23
    • 73449112996 scopus 로고    scopus 로고
    • Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU
    • Liu G, Hu X, Chakrabarty S. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU. Int J Cancer 2010; 126: 631-9.
    • (2010) Int J Cancer , vol.126 , pp. 631-639
    • Liu, G.1    Hu, X.2    Chakrabarty, S.3
  • 24
    • 0025935613 scopus 로고
    • Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates
    • Studzinski GP, Reddy KB, Hill HZ, Bhandal AK. Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates. Cancer Res 1991; 51: 3451-5.
    • (1991) Cancer Res , vol.51 , pp. 3451-3455
    • Studzinski, G.P.1    Reddy, K.B.2    Hill, H.Z.3    Bhandal, A.K.4
  • 25
    • 0026697840 scopus 로고
    • Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol
    • Slapak CA, Desforges JF, Fogaren T, Miller KB. Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol. Am J Hematol 1992; 41: 178-83.
    • (1992) Am J Hematol , vol.41 , pp. 178-183
    • Slapak, C.A.1    Desforges, J.F.2    Fogaren, T.3    Miller, K.B.4
  • 26
    • 2542466836 scopus 로고    scopus 로고
    • Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome
    • Ferrero D, Campa E, Dellacasa C, Campana S, Foli C, Boccadoro M. Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome. Haematologica 2004; 89: 619-20.
    • (2004) Haematologica , vol.89 , pp. 619-620
    • Ferrero, D.1    Campa, E.2    Dellacasa, C.3    Campana, S.4    Foli, C.5    Boccadoro, M.6
  • 27
    • 0033990705 scopus 로고    scopus 로고
    • Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs
    • Niitsu N, Umeda M, Honma Y. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs. Leuk Res 2000; 24: 1-9.
    • (2000) Leuk Res , vol.24 , pp. 1-9
    • Niitsu, N.1    Umeda, M.2    Honma, Y.3
  • 28
    • 0031985235 scopus 로고    scopus 로고
    • Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea
    • Makishima M, Okabe-Kado J, Honma Y. Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea. Br J Cancer 1998; 77: 33-9.
    • (1998) Br J Cancer , vol.77 , pp. 33-39
    • Makishima, M.1    Okabe-Kado, J.2    Honma, Y.3
  • 29
    • 33846581566 scopus 로고    scopus 로고
    • Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer
    • Sternberg CN, Donat SM, Bellmunt J, et al. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology 2007; 69: 62-79.
    • (2007) Urology , vol.69 , pp. 62-79
    • Sternberg, C.N.1    Donat, S.M.2    Bellmunt, J.3
  • 31
    • 77954277193 scopus 로고    scopus 로고
    • 1,25D(3) Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models
    • Ma Y, Yu WD, Trump DL, Johnson CS. 1,25D(3) Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer 2010; 116: 3294-303.
    • (2010) Cancer , vol.116 , pp. 3294-3303
    • Ma, Y.1    Yu, W.D.2    Trump, D.L.3    Johnson, C.S.4
  • 32
    • 77956831569 scopus 로고    scopus 로고
    • Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system
    • in press
    • Yu WD, Ma Y, Flynn G, et al. Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system. Cell Cycle 2010; in press.
    • Cell Cycle 2010
    • Yu, W.D.1    Ma, Y.2    Flynn, G.3
  • 33
    • 0034896572 scopus 로고    scopus 로고
    • Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis
    • Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res 2001; 7: 1043-51.
    • (2001) Clin Cancer Res , vol.7 , pp. 1043-1051
    • Hershberger, P.A.1    Yu, W.D.2    Modzelewski, R.A.3    Rueger, R.M.4    Johnson, C.S.5    Trump, D.L.6
  • 34
    • 0034086039 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death
    • Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 2000; 60: 2040-8.
    • (2000) Cancer Res , vol.60 , pp. 2040-2048
    • Wang, Q.1    Yang, W.2    Uytingco, M.S.3    Christakos, S.4    Wieder, R.5
  • 35
    • 33845599555 scopus 로고    scopus 로고
    • Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha, 25-dihydroxyvitamin D3
    • Ting HJ, Hsu J, Bao BY, Lee YF. Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3. Cancer Lett 2007; 247: 122-9.
    • (2007) Cancer Lett , vol.247 , pp. 122-129
    • Ting, H.J.1    Hsu, J.2    Bao, B.Y.3    Lee, Y.F.4
  • 36
    • 0032928303 scopus 로고    scopus 로고
    • Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo
    • Koshizuka K, Koike M, Asou H, et al. Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo. Breast Cancer Res Treat 1999; 53: 113-20.
    • (1999) Breast Cancer Res Treat , vol.53 , pp. 113-120
    • Koshizuka, K.1    Koike, M.2    Asou, H.3
  • 37
    • 0034744476 scopus 로고    scopus 로고
    • The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells
    • Chaudhry M, Sundaram S, Gennings C, Carter H, Gewirtz DA. The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells. Cancer Chemother Pharmacol 2001; 47: 429-36.
    • (2001) Cancer Chemother Pharmacol , vol.47 , pp. 429-436
    • Chaudhry, M.1    Sundaram, S.2    Gennings, C.3    Carter, H.4    Gewirtz, D.A.5
  • 38
    • 1842868727 scopus 로고    scopus 로고
    • Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells
    • Ikeda N, Uemura H, Ishiguro H, et al. Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells. Mol Cancer Ther 2003; 2: 739-46.
    • (2003) Mol Cancer Ther , vol.2 , pp. 739-746
    • Ikeda, N.1    Uemura, H.2    Ishiguro, H.3
  • 39
    • 0031036661 scopus 로고    scopus 로고
    • Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid
    • Elstner E, Linker-Israeli M, Le J, et al. Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid. J Clin Invest 1997; 99: 349-60.
    • (1997) J Clin Invest , vol.99 , pp. 349-360
    • Elstner, E.1    Linker-Israeli, M.2    Le, J.3
  • 40
    • 8044226035 scopus 로고    scopus 로고
    • Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells
    • Elstner E, Linker-Israeli M, Umiel T, et al. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 1996; 56: 3570-6.
    • (1996) Cancer Res , vol.56 , pp. 3570-3576
    • Elstner, E.1    Linker-Israeli, M.2    Umiel, T.3
  • 41
    • 0035810045 scopus 로고    scopus 로고
    • Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A
    • Rashid SF, Moore JS, Walker E, et al. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 2001; 20: 1860-72.
    • (2001) Oncogene , vol.20 , pp. 1860-1872
    • Rashid, S.F.1    Moore, J.S.2    Walker, E.3
  • 42
    • 0043236062 scopus 로고    scopus 로고
    • 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells
    • Dunlap N, Schwartz GG, Eads D, et al. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer 2003; 89: 746-53.
    • (2003) Br J Cancer , vol.89 , pp. 746-753
    • Dunlap, N.1    Schwartz, G.G.2    Eads, D.3
  • 43
    • 0038276041 scopus 로고    scopus 로고
    • The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice
    • Sundaram S, Sea A, Feldman S, et al. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 2003; 9: 2350-6.
    • (2003) Clin Cancer Res , vol.9 , pp. 2350-2356
    • Sundaram, S.1    Sea, A.2    Feldman, S.3
  • 44
    • 67650351201 scopus 로고    scopus 로고
    • Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation
    • Mineva ND, Wang X, Yang S, et al. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol 2009; 220: 593-9.
    • (2009) J Cell Physiol , vol.220 , pp. 593-599
    • Mineva, N.D.1    Wang, X.2    Yang, S.3
  • 45
    • 73349127819 scopus 로고    scopus 로고
    • Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells
    • Cicarma E, Tuorkey M, Juzeniene A, Ma LW, Moan J. Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells. Br J Dermatol 2009; 161: 413-8.
    • (2009) Br J Dermatol , vol.161 , pp. 413-418
    • Cicarma, E.1    Tuorkey, M.2    Juzeniene, A.3    Ma, L.W.4    Moan, J.5
  • 46
    • 42449162971 scopus 로고    scopus 로고
    • Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling
    • Jamshidi F, Zhang J, Harrison JS, Wang X, Studzinski GP. Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling. Cell Cycle 2008; 7: 917-24.
    • (2008) Cell Cycle , vol.7 , pp. 917-924
    • Jamshidi, F.1    Zhang, J.2    Harrison, J.S.3    Wang, X.4    Studzinski, G.P.5
  • 47
    • 23344449304 scopus 로고    scopus 로고
    • The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth
    • Gavrilov V, Steiner M, Shany S. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth. Anticancer Res 2005; 25: 3425-9.
    • (2005) Anticancer Res , vol.25 , pp. 3425-3429
    • Gavrilov, V.1    Steiner, M.2    Shany, S.3
  • 48
    • 0036054309 scopus 로고    scopus 로고
    • Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells
    • Funato K, Miyazawa K, Yaguchi M, Gotoh A, Ohyashiki K. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells. Leukemia 2002; 16: 1519-27.
    • (2002) Leukemia , vol.16 , pp. 1519-1527
    • Funato, K.1    Miyazawa, K.2    Yaguchi, M.3    Gotoh, A.4    Ohyashiki, K.5
  • 49
    • 0037444401 scopus 로고    scopus 로고
    • Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium
    • Danilenko M, Wang Q, Wang X, Levy J, Sharoni Y, Studzinski GP. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res 2003; 63: 1325-32.
    • (2003) Cancer Res , vol.63 , pp. 1325-1332
    • Danilenko, M.1    Wang, Q.2    Wang, X.3    Levy, J.4    Sharoni, Y.5    Studzinski, G.P.6
  • 50
    • 1242316960 scopus 로고    scopus 로고
    • 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression
    • Clark CS, Konyer JE, Meckling KA. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Exp Cell Res 2004; 294: 301-11.
    • (2004) Exp Cell Res , vol.294 , pp. 301-311
    • Clark, C.S.1    Konyer, J.E.2    Meckling, K.A.3
  • 51
    • 0032588622 scopus 로고    scopus 로고
    • Bryostatin-1 and 1alpha,25-dihydroxyvitamin D3 synergistically stimulate the differentiation of NB4 acute promyelocytic leukemia cells
    • Song XD, Norman AW. Bryostatin-1 and 1alpha,25-dihydroxyvitamin D3 synergistically stimulate the differentiation of NB4 acute promyelocytic leukemia cells. Leukemia 1999; 13: 275-81.
    • (1999) Leukemia , vol.13 , pp. 275-281
    • Song, X.D.1    Norman, A.W.2
  • 52
    • 77951046942 scopus 로고    scopus 로고
    • Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
    • Callens C, Coulon S, Naudin J, et al. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med 2010; 207: 731-50.
    • (2010) J Exp Med , vol.207 , pp. 731-750
    • Callens, C.1    Coulon, S.2    Naudin, J.3
  • 53
    • 0032554056 scopus 로고    scopus 로고
    • Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone
    • Yu WD, McElwain MC, Modzelewski RA, et al. Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 1998; 90: 134-41.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 134-141
    • Yu, W.D.1    McElwain, M.C.2    Modzelewski, R.A.3
  • 54
    • 0035542953 scopus 로고    scopus 로고
    • Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling
    • Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS. Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res 2001; 7: 4164-73.
    • (2001) Clin Cancer Res , vol.7 , pp. 4164-4173
    • Bernardi, R.J.1    Trump, D.L.2    Yu, W.D.3    McGuire, T.F.4    Hershberger, P.A.5    Johnson, C.S.6
  • 56
    • 0036784267 scopus 로고    scopus 로고
    • Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells
    • Peehl DM, Seto E, Hsu JY, Feldman D. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells. J Urol 2002; 168: 1583-8.
    • (2002) J Urol , vol.168 , pp. 1583-1588
    • Peehl, D.M.1    Seto, E.2    Hsu, J.Y.3    Feldman, D.4
  • 57
    • 0033324493 scopus 로고    scopus 로고
    • Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
    • Ly LH, Zhao XY, Holloway L, Feldman D. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 1999; 140: 2071-6.
    • (1999) Endocrinology , vol.140 , pp. 2071-2076
    • Ly, L.H.1    Zhao, X.Y.2    Holloway, L.3    Feldman, D.4
  • 58
    • 58849087664 scopus 로고    scopus 로고
    • RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects
    • Yin Y, Ni J, Chen M, Guo Y, Yeh S. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects. Clin Cancer Res 2009; 15: 190-200.
    • (2009) Clin Cancer Res , vol.15 , pp. 190-200
    • Yin, Y.1    Ni, J.2    Chen, M.3    Guo, Y.4    Yeh, S.5
  • 60
    • 1542720378 scopus 로고    scopus 로고
    • Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells
    • Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C, Cramer SD. Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res 2004; 64: 2143-7.
    • (2004) Cancer Res , vol.64 , pp. 2143-2147
    • Rao, A.1    Coan, A.2    Welsh, J.E.3    Barclay, W.W.4    Koumenis, C.5    Cramer, S.D.6
  • 61
    • 24344448674 scopus 로고    scopus 로고
    • Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity
    • Swami S, Krishnan AV, Peehl DM, Feldman D. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity. Mol Cell Endocrinol 2005; 241: 49-61.
    • (2005) Mol Cell Endocrinol , vol.241 , pp. 49-61
    • Swami, S.1    Krishnan, A.V.2    Peehl, D.M.3    Feldman, D.4
  • 62
    • 67049156854 scopus 로고    scopus 로고
    • Enhancement of 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced HL-60 leukemia cell differentiation by Panax ginseng
    • Kim SH, Cho SS, Simkhada JR, et al. Enhancement of 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced HL-60 leukemia cell differentiation by Panax ginseng. Biosci Biotechnol Biochem 2009; 73: 1048-53.
    • (2009) Biosci Biotechnol Biochem , vol.73 , pp. 1048-1053
    • Kim, S.H.1    Cho, S.S.2    Simkhada, J.R.3
  • 63
    • 35148840489 scopus 로고    scopus 로고
    • S179D prolactin sensitizes human prostate cancer cell s such that physi ol ogi cal concentrati ons of 1,25 dihydroxy vitamin D3 result in growth inhibition and cell death
    • Wu W, Zanello L, Walker AM. S179D prolactin sensitizes human prostate cancer cell s such that physi ol ogi cal concentrati ons of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death. Prostate 2007; 67: 1498-506.
    • (2007) Prostate , vol.67 , pp. 1498-1506
    • Wu, W.1    Zanello, L.2    Walker, A.M.3
  • 64
    • 33846813508 scopus 로고    scopus 로고
    • Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy
    • Taghizadeh F, Tang MJ, Tai IT. Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy. Mol Cancer Ther 2007; 6: 309-17.
    • (2007) Mol Cancer Ther , vol.6 , pp. 309-317
    • Taghizadeh, F.1    Tang, M.J.2    Tai, I.T.3
  • 65
    • 3042596692 scopus 로고    scopus 로고
    • Anti-tumor activity of calcitriol: pre-clinical and clinical studies
    • Trump DL, Hershberger PA, Bernardi RJ, et al. Anti-tumor activity of calcitriol: pre-clinical and clinical studies. J Steroid Biochem Mol Biol 2004; 89-90: 519-26.
    • (2004) J Steroid Biochem Mol Biol , vol.89-90 , pp. 519-526
    • Trump, D.L.1    Hershberger, P.A.2    Bernardi, R.J.3
  • 66
    • 77149128673 scopus 로고    scopus 로고
    • Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy
    • Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J 2010; 16: 1-9.
    • (2010) Cancer J , vol.16 , pp. 1-9
    • Trump, D.L.1    Deeb, K.K.2    Johnson, C.S.3
  • 67
  • 68
    • 1642566524 scopus 로고    scopus 로고
    • Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses
    • Muindi JR, Modzelewski RA, Peng Y, Trump DL, Johnson CS. Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses. Oncology 2004; 66: 62-6.
    • (2004) Oncology , vol.66 , pp. 62-66
    • Muindi, J.R.1    Modzelewski, R.A.2    Peng, Y.3    Trump, D.L.4    Johnson, C.S.5
  • 69
    • 0032978243 scopus 로고    scopus 로고
    • A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy
    • Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin Cancer Res 1999; 5: 1339-45.
    • (1999) Clin Cancer Res , vol.5 , pp. 1339-1345
    • Smith, D.C.1    Johnson, C.S.2    Freeman, C.C.3    Muindi, J.4    Wilson, J.W.5    Trump, D.L.6
  • 70
    • 33947250294 scopus 로고    scopus 로고
    • A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
    • Fakih MG, Trump DL, Muindi JR, et al. A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors. Clin Cancer Res 2007; 13: 1216-23.
    • (2007) Clin Cancer Res , vol.13 , pp. 1216-1223
    • Fakih, M.G.1    Trump, D.L.2    Muindi, J.R.3
  • 71
    • 0035875881 scopus 로고    scopus 로고
    • A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation
    • Beer TM, Munar M, Henner WD. A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. Cancer 2001; 91: 2431-9.
    • (2001) Cancer , vol.91 , pp. 2431-2439
    • Beer, T.M.1    Munar, M.2    Henner, W.D.3
  • 72
    • 0036913420 scopus 로고    scopus 로고
    • Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel
    • Muindi JR, Peng Y, Potter DM, et al. Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther 2002; 72: 648-59.
    • (2002) Clin Pharmacol Ther , vol.72 , pp. 648-659
    • Muindi, J.R.1    Peng, Y.2    Potter, D.M.3
  • 73
    • 33847121998 scopus 로고    scopus 로고
    • Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer
    • Beer TM, Javle MM, Ryan CW, et al. Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemother Pharmacol 2007; 59: 581-7.
    • (2007) Cancer Chemother Pharmacol , vol.59 , pp. 581-587
    • Beer, T.M.1    Javle, M.M.2    Ryan, C.W.3
  • 74
    • 27744528525 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer
    • Beer TM, Javle M, Lam GN, Henner WD, Wong A, Trump DL. Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer. Clin Cancer Res 2005; 11: 7794-9.
    • (2005) Clin Cancer Res , vol.11 , pp. 7794-7799
    • Beer, T.M.1    Javle, M.2    Lam, G.N.3    Henner, W.D.4    Wong, A.5    Trump, D.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.